Previous article
Continuity Matters: Financial Impact of the G2211 Code in Primary Care
Aug 2024
Next article
Diagnosing Dementia and Cognitive Impairment in Symptomatic Patients
Cochrane for Clinicians

Blood Pressure Control for Patients With Diabetic Retinopathy

Leesha Helm, MD, MPH,
Mary Joyce Green, MD,
Penn State Hershey Medical Center, Hershey, Pennsylvania

American Family Physician. 2024;110(2):131-132.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

  1. 1.Do DV, Han G, Abariga SA, et al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2023(3):CD006127.
  2. 2.Kempen JH, O’Colmain BJ, Leske MC, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
  3. 3.Nathan DM, Genuth S, Lachin J, et al.; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
  4. 4.UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [published correction appears in Lancet. 1999; 354(9178): 602]. Lancet. 1998;352(9131):837-853.
  5. 5.Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy [published correction appears in Lancet. 2000; 356(9232): 860]. Lancet. 2000;355(9200):253-259.
  6. 6.Klein R, Klein BE, Moss SE, et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?. Arch Intern Med. 1989;149(11):2427-2432.
  7. 7.Klein R, Klein BEK. Blood pressure control and diabetic retinopathy. Br J Ophthalmol. 2002;86(4):365-367.
  8. 8.Sjølie AK, Dodson P, Hobbs FRR. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int J Clin Pract. 2011;65(2):148-153.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

Previous article
Continuity Matters: Financial Impact of the G2211 Code in Primary Care
Aug 2024
Next article
Diagnosing Dementia and Cognitive Impairment in Symptomatic Patients

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.